Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Erstveröffentlichung

2017

Authors

Meininger, Vincent

Genge, Angela

van den Berg, Leonard H.

Robberecht, Wim

Ludolph, Albert C.

et al.

Wissenschaftlicher Artikel

Published in

Lancet Neurology ; 16 (2017), 3. - S. 208-216. - ISSN 1474-4422. - eISSN 1474-4465

Link to publication

https://dx.doi.org/10.1016/S1474-4422(16)30399-4

Institutions

UKU. Klinik für Neurologie

Subject headings

[Free subject headings]: riluzole serum concentrations | neurite outgrowth inhibitor | nogo-a | clinical-trials | therapeutic trials | expression | als | denervation | diagnosis | disease
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record